
Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Category: Biotech/Pharma News
-
By Donald Zuhn –- A report issued by PwC's Health Research Institute (HRI) in June projects next year's medical cost trend (i.e., the projected percentage increase in the cost to treat patients) to be 6.5%, which is level to the medical cost trend for 2016 and comparable to the medical cost trend for the past…
-
By Kevin E. Noonan — One of the effective arguments made by the ACLU in the AMP v. Myriad case was that somehow permitting patents on genes implicated a patient's privacy right in her genetic material. This was also the theme of their public relations campaign to raise money and gain members, and when the…
-
By Kevin E. Noonan — The rise and spread of the Zika virus, although limited for now to South America, has raised concerns globally, particularly with the prospect of the Summer Olympics in Rio de Janeiro later this year. And with those concerns comes renewed interest in the insect vector associated with zika virus transmission,…
-
The gut microbiome, a collection of microbes living in the gastrointestinal tract, has emerged as an attractive target for pharmaceutical intervention for the treatment of a variety of disorders. This is the fourth article in a series on advancements in microbiome research and development. This installment will focus on the connections between the gut microbiome…
-
Editor's note: This is the fourth article in a series on advancements in microbiome research and development. By Jessica Miles* and Anthony D. Sabatelli** — Early last month, the Jackson Laboratory for Genomic Medicine in Farmington, CT held its second annual symposium, "Microbiome Meets Cancer and Immunology." This year's event came on the heels of…
-
By Kevin E. Noonan — Invertebrate zoology is in many ways the most comprehensive survey course on biology, encompassing most multicellular life on the planet. (Indeed, the study of the Order Coleoptera alone, comprising the beetles, would satisfy that criterion: J.B.S. Haldane once remarked that what his study of biology had taught him about God…
-
This is the second article in a series on advancements in microbiome research and development. This installment reviews US patents issued in 2015 in "Microbiomics." Upcoming articles will continue to review important topics in this technology area, and patents of interest. By Jessica Miles* and Anthony D. Sabatelli** — Microbiome-related therapies typically involve compositions containing…
-
Editor's note: This is the first part in a series that will explore the current and potential developments of microbiome research, and how those developments interface with intellectual property protection. By Jessica Miles* and Anthony D. Sabatelli** — This is the first installment in a series on advancements in microbiome research and development. Our goal…
-
By Donald Zuhn — Earlier this month, Rare Genomics Institute, an international non-profit that makes cutting edge research technologies of genome sequencing, physicians and scientists around the world accessible to rare disease patients, announced the Amplify Hope Initiative, a new study aimed at determining how crowdfunding can promote scientific research to help rare disease patients. …
-
By Kevin E. Noonan — One of the promises of the Human Genome Project was that knowledge of the entirety of the human genetic complement would permit researchers to identify genetic bases for diseases that had been intractable to conventional approaches. While these efforts have borne equivocal fruit much more slowly that expected or hoped,…